ATC code N04

ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N04 is part of the anatomical group N Nervous system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N04AA01 Trihexyphenidyl N04AA02 Biperiden N04AA03 Metixene N04AA04 Procyclidine N04AA05 Profenamine N04AA08 Dexetimide N04AA09 Phenglutarimide N04AA10 Mazaticol N04AA11 Bornaprine N04AA12 Tropatepine N04AB01 Etanautine N04AB02 Orphenadrine (chloride) N04AC01 Benzatropine N04AC30 Etybenzatropine N04BA01 Levodopa N04BA02 Levodopa and decarboxylase inhibitor N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor N04BA04 Melevodopa N04BA05 Melevodopa and decarboxylase inhibitor N04BA06 Etilevodopa and decarboxylase inhibitor N04BA07 Foslevodopa and decarboxylase inhibitor N04BB01 Amantadine N04BC01 Bromocriptine N04BC02 Pergolide N04BC03 Dihydroergocryptine mesylate N04BC04 Ropinirole N04BC05 Pramipexole N04BC06 Cabergoline N04BC07 Apomorphine N04BC08 Piribedil N04BC09 Rotigotine N04BD01 Selegiline N04BD02 Rasagiline N04BD03 Safinamide N04BX01 Tolcapone N04BX02 Entacapone N04BX03 Budipine N04BX04 Opicapone N04CX01 Istradefylline